StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 08/21/2013 -- Cellceutix Corp(OTCBB:CTIX) ended its day with the gaining stream with the gain of +0.50% and closed at the price of $2.00 after opening at $2.00. Stock traded during its last trading session with the total traded volume of 70,890.00 shares as compared to its average volume of 326,022.00 shares.
During last 5 trades the stock jumped almost +3.09%, and during last one month it slipped with the percentage of -9.91. CTIX’s total market capitalization is $186.35 million along with 93.17 million shares outstanding. Cellceutix Corporation, a development stage biopharmaceutical company, engages in the discovery and development of small molecule drugs to treat diseases primarily in the areas of cancer and inflammatory disease. Its product candidates include Kevetrin, which is in Phase 1 trial for various solid tumor cancer types in patients with advanced-stage cancers; and various preclinical stage products comprising KM-133 for the treatment of psoriasis; KM 391 for the treatment of autism; KM 277 for the treatment of arthritis; and KM 278 for the treatment of asthma and osteoarthritis. The company?s products under early research and development consist of KM 362 for the treatment of MS/ALS/Parkinsons diseases; KM-3174 for the treatment of cancer; and KM-732 for the treatment of hypertensive emergency. Cellceutix Corporation was founded in 2007 and is headquartered in Beverly, Massachusetts.
For How Long CTIX will Fight for Profitability? Read This Trend Analysis report
MediSwipe Inc(OTCMKTS:MWIP) started its trading session with the price $0.05, and closed at price of $0.0439 by losing -5.18%.
Previous 5 days graph demonstrated an optimistic move of +5.28%. MWIP’s quarterly performance remained green with the percentage of +9.75.
MWIP’s stocks traded with total volume of 1.02 million shares while the average trading capacity remained 1.79 million shares. MediSwipe, Inc. provides patient solutions for electronically processing transactions within the healthcare industry in the United States.
Has MWIP Found The Bottom And Ready To Gain Momentum? Find Out Here
Writer s Group Film Corp(OTCMKTS:WRIT) opened its shares at the price of $0.0004 for the day, its closing price was $0.0004 after losing -20.00% for the day. The company traded with the total volume of 64.69 million shares while its average trading aptitude remained 41.58 million shares. The beta of the WRIT stands at 1.58.Its year to date performance remained adverse with -20%.
The company has total of 2.25 billion outstanding shares and its total market capitalization is $898,378.00 . Writers? Group Film Corp., a content creation company, focuses on the production, acquisition, and distribution of live concerts in three dimensional format (3D) for digital broadcast into digitally-enabled movie theaters in the United States and internationally. The company would licenses its products in 2D and 3D format to DVD and Blu-Ray retailers, TV broadcasters, cable and 3D cable channels, and mobile streaming providers; and sells merchandising, such as clothing, household goods, and other products in movie theaters, where the live concert is exhibited. The company was formerly known as Front Row Networks, Inc. and changed its name to Writers' Group Film Corp in February 2011. Writers? Group Film Corp. is based in Beverly Hills, California.
Why Should Investors Buy WRIT After the Recent Fall? Just Go Here and Find Out
VUZIX CORP CMN STK(OTCBB:VUZI) stock is at $2.29, up +6.02 percent from its previous close of $2.16. The stock opened the session at $2.20 and touched its highest price point at $2.38. VUZI stock’s lowest price point for the session stood at $2.17.
Stocks graphical chart shows a bearish trend during its last one month’s trading session. It remained negative with -67.7% during previous three months trade. Its recent trading volume was 162,136.00 shares in comparison to its usual trading volume of 92,585.00 shares. Vuzix Corporation engages in the design, manufacture, marketing, and sale of products for use in the consumer, and media and entertainment markets.
Why Should Investors Buy VUZI After The Recent Gain? Just Go Here and Find Out
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)